Search results
Johnson and Johnson Offers to Pay $6.5 Billion to Settle Talcum Powder Cancer Lawsuits
People via Yahoo Finance· 7 days agoJohnson and Johnson reiterated in its statement on Wednesday, May 1, that “none of the talc-related...
How Johnson & Johnson's $6.475 Billion Talc Settlement Impacts Black Women
Forbes· 2 days agoPharmaceutical giant Johnson & Johnson is set to pay $6.475 billion to settle lawsuits alleging its...
Johnson & Johnson offers $6.5 billion settlement in baby powder cancer lawsuits
KTVI via Yahoo News· 6 days agoJohnson & Johnson is offering to pay nearly six and a half billion dollars in a settlement deal. The...
Tom Brady telling off Jeff Ross was not scripted, Drew Bledsoe confirms
TheStreet.com· 2 days agoDuring Brady's roast, the NFL legend interrupted Ross after he made a joke after Robert Kraft. "The Roast of Tom Brady" was filled with a ton of laughs, even if the jokes would at times reach ...
Commissioners distribute opioid funds to Salvation Army, growth council
Gannett via AOL· 5 hours agoPurdue Pharma was implicated, as well as Cardinal Health, McKesson, AmerisourceBergen, and Johnson and Johnson for distributing opioid ...
A Look at Pharma ETFs Post Q1 Earnings
Zacks via Yahoo Finance· 1 day agoLet’s delve deeper into the earnings of some of the bigwigs: Earnings in Focus Johnson and Johnson Johnson & Johnson JNJ continued with ...
Johnson & Johnson offers to pay $6.5 billion to settle talc ovarian cancer lawsuits - WDEF
WDEF Chattanooga· 6 days agoJohnson & Johnson said Wednesday it has offered to pay $6.5 billion to settle allegations that its...
Exclusive: In Tesla Autopilot probe, US prosecutors focus on securities, wire fraud
Reuters· 5 hours ago, opens new tab committed securities or wire fraud by misleading investors and consumers about its...
Johnson & Johnson Highlights Commitment to Transform Treatment of Retinal Diseases at ARVO 2024
WTRF Wheeling· 6 days agoJohnson & Johnson today announced that eight company-sponsored presentations will be featured during the Association for Research in Vision and Ophthalmology (ARVO) 2024 Annual Meeting taking ...
Moderna’s sales from its only product, the COVID-19 vaccine, fell 91% from last year
AOL· 6 days agoThe dark days of the pandemic are finally in the past for most of us—and that seems to be reflected in the earnings for Moderna, whose revenue is dependent on sales of its COVID-19 vaccine.